Serum leptin levels and their relationship to tumor necrosis factor-alpha and interleukin-6 in neonatal sepsis. 2003

Esin Koç, and Gonca Ustündağ, and Didem Aliefendioğlu, and Ebru Ergenekon, and Aysun Bideci, and Yildiz Atalay
Department of Neonatology, Faculty of Medicine, Gazi University, Ankara, Turkey. esin@med.gazi.edu.tr

Circulating leptin concentrations are raised in animal models of inflammation and sepsis and leptin production is also increased in rodents by administration of endotoxin or cytokines. The purpose of this study was to investigate the effect of sepsis on serum leptin concentration and whether circulating leptin was related to tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) release in newborn infants. Plasma leptin, TNF-alpha and IL-6 were measured in 20 neonates with culture-proven sepsis as soon as sepsis was diagnosed and after recovery and in 15 healthy control infants. There was no significant difference in plasma leptin levels between septic and control infants (p > 0.05); there was also no difference in plasma leptin levels in septic neonates before and after therapy (p > 0.05). No relationship between leptin and TNF-alpha (r = 0.16, p > 0.05) or IL-6 (r = 0.12, p > 0.05) was identified. These findings suggest that a major role of leptin in acute neonatal sepsis appears unlikely.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007710 Klebsiella Infections Infections with bacteria of the genus KLEBSIELLA. Infections, Klebsiella,Infection, Klebsiella,Klebsiella Infection
D008297 Male Males
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002177 Candidiasis Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections

Related Publications

Esin Koç, and Gonca Ustündağ, and Didem Aliefendioğlu, and Ebru Ergenekon, and Aysun Bideci, and Yildiz Atalay
June 2003, Pediatric emergency care,
Esin Koç, and Gonca Ustündağ, and Didem Aliefendioğlu, and Ebru Ergenekon, and Aysun Bideci, and Yildiz Atalay
April 1993, Pediatric research,
Esin Koç, and Gonca Ustündağ, and Didem Aliefendioğlu, and Ebru Ergenekon, and Aysun Bideci, and Yildiz Atalay
October 2006, Saudi medical journal,
Esin Koç, and Gonca Ustündağ, and Didem Aliefendioğlu, and Ebru Ergenekon, and Aysun Bideci, and Yildiz Atalay
August 2004, The Medical journal of Malaysia,
Esin Koç, and Gonca Ustündağ, and Didem Aliefendioğlu, and Ebru Ergenekon, and Aysun Bideci, and Yildiz Atalay
August 1997, American journal of perinatology,
Esin Koç, and Gonca Ustündağ, and Didem Aliefendioğlu, and Ebru Ergenekon, and Aysun Bideci, and Yildiz Atalay
January 2008, Mediators of inflammation,
Esin Koç, and Gonca Ustündağ, and Didem Aliefendioğlu, and Ebru Ergenekon, and Aysun Bideci, and Yildiz Atalay
April 2006, Pediatrics international : official journal of the Japan Pediatric Society,
Esin Koç, and Gonca Ustündağ, and Didem Aliefendioğlu, and Ebru Ergenekon, and Aysun Bideci, and Yildiz Atalay
March 2007, The Australian and New Zealand journal of psychiatry,
Esin Koç, and Gonca Ustündağ, and Didem Aliefendioğlu, and Ebru Ergenekon, and Aysun Bideci, and Yildiz Atalay
October 2005, Indian pediatrics,
Esin Koç, and Gonca Ustündağ, and Didem Aliefendioğlu, and Ebru Ergenekon, and Aysun Bideci, and Yildiz Atalay
November 2012, European review for medical and pharmacological sciences,
Copied contents to your clipboard!